Skip to main content Accessibility help
×
Home
  • Print publication year: 2013
  • Online publication date: August 2013

Chapter 24 - Laparoscopic evaluation and management of adnexal masses and ovarian cancer

Related content

Powered by UNSILO

References

1. American Cancer Society. Cancer Facts & Figures, 2011. Atlanta, GA: ACS; 2011.
2. Moore DH. Primary surgical management of early epithelial ovarian carcinoma. In: Rubin SC, Sutton GP (Eds.). Ovarian Cancer. 2nd edition. Philadelphia: Lippincott Williams & Wilkins; 2001. p 201–18.
3. Nezhat F, Nezhat C, Welander CE, et al. Four ovarian cancers diagnosed during laparoscopic management of 1011 women with adnexal masses. Am J Obstet Gynecol. 1992;167:790–6.
4. Liu CS, Nagarsheth NP, Nezhat FR. Laparoscopy and ovarian cancer: a paradigm change in the management of ovarian cancer? J Minim Invasive Gynecol. 2009;16:250–62.
5. Querleu D, Leblanc E. Laparoscopic infrarenal para-aortic lymph node dissection for restaging of carcinoma of the ovary or fallopian tube. Cancer. 1994;73:1467–71.
6. Childers JM, Lang J, Surwit EA, et al. Laparoscopic surgical staging of ovarian cancer. Gynecol Oncol. 1995;59:25–33.
7. Spirtos NM, Eisekop SM, Boike G, et al. Laparoscopic staging in patients with incompletely staged cancers of the uterus, ovary, fallopian tube, and primary peritoneum: a Gynecologic Oncology Group (GOG) study. Am J Obstet Gynecol. 2005;193:1645–9.
8. Tozzi R, Kohler C, Ferrara A, et al. Laparoscopic treatment of early ovarian cancer: surgical and survival outcomes. Gynecol Oncol. 2004;93:199–203.
9. Tozzi R, Schneider A. Laparoscopic treatment of early ovarian cancer. Curr Opin Obstet Gynecol. 2005;17:354–8.
10. Curtin JP. Management of the adnexal mass. Gynecol Oncol. 1994;55:S42–6.
11. Sassone A, Timor-Tritch I, Artner A, et al. Transvaginal sonographic characterization of ovarian disease: evaluation of a new scoring system to predict ovarian malignancy. Obstet Gynecol. 1991;78:7–11.
12. Alcazar JL, Jurado M. Prospective evaluation of a logistic model based on sonographic morphologic and color Doppler findings developed to predict adnexal malignancy. J Ultrasound Med. 1999;18:837–43.
13. Romagnolo C, Gadducci A, Sartori E, et al. Management of borderline ovarian tumors: results of an Italian multicenter study. Gynecol Oncol. 2006;101:255–60.
14. Camatte S, Morice P, Pautier P, et al. Fertility results after conservative treatment of advanced stage serous borderline tumors of the ovary. BJOG. 2002;109:373–80.
15. Nezhat F, Nezhat C, Burrell M. Laparoscopically assisted hysterectomy for the management of a borderline ovarian tumor: a case report. J Laparoendosc Surg. 1992;2:167–9.
16. Darai E, Teboul J, Fauconnier A, et al. Management and outcome of borderline ovarian tumors incidentally discovered at or after laparoscopy. Acta Obstet Gynecol Scand. 1998;77:451–7.
17. Seracchioli S, Venturoli FM, Colombo F, et al. Fertility and tumor recurrence rate after conservative laparoscopic management of young women with early-stage borderline ovarian tumors. Fertil Steril. 2001;76:999–1004.
18. Fauvet J, Boccara C, Dufournet C, et al. Laparoscopic management of borderline ovarian tumors: results of a French multicenter study. Ann Oncol. 2005;16:403–10.
19. LeBlanc E, Querleu D, Narducci F, et al. Laparoscopic restaging of early stage invasive adnexal tumors: a 10-year experience. Gynecol Oncol. 2004;94:624–9.
20. Le T, Adolph A, Krepart GV, et al. The benefits of comprehensive surgical staging in the management of early stage epithelial ovarian carcinoma. Gynecol Oncol. 2002;85:351–5.
21. Park JY, Kim DY, Suh DS, et al. Comparison of laparoscopy and laparotomy in surgical staging of early-stage ovarian and fallopian tubal cancer. Ann Surg Oncol. 2008;15:2012–19.
22. Nezhat F, Ezzati M, Rahaman J, et al. Laparoscopic management of early ovarian and fallopian tube cancers: surgical and survival outcome. Am J Obstet Gynecol. 2009;83:e1–6.
23. Barakat RR, Markman M, Randall ME. Principles and Practice of Gynecologic Oncology, 5th edition. Philadelphia: Lippincott Williams & Wilkins; 2009.
24. Katz VL, Lentz GM, Lobo RA, Gershenson DM. Comprehensive Gynecology, 5th edition. Philadelphia: Mosby Elsevier; 2007.
25. Bristow RE, Tomacruz SR, Armstrong DK, et al. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platino-era: a meta analysis. J Clin Oncol. 2002;20:1248–59.
26. Winter WE III, Maxwell GL, Tian C, et al. Gynecologic Oncology Group Study. Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study. J Clin Oncol. 2007;25:3621–7.
27. Winter WE III, Maxwell GL, Tian C, et al. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study. J Clin Oncol. 2008;26:83–9.
28. Du Bois A, Reuss A, Pujade-Lauraine E, et al. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d’ Investigateurs Nationaux Pour les Etudes des Cancers l’Ovaire (GINECO). Cancer. 2009;115:1234–44.
29. Hoskins WJ, Bundy BN, Thigpen JT, et al. The influence of cytoreductive surgery on recurrence-free survival in small volume stage III epithelial ovarian cancer: a gynecologic oncology group study. Gynecol Oncol. 1992;47:159–66.
30. Bristow RE, Duska LR, Lambrou NC, et al. A model for predicting surgical outcome in patient with advanced ovarian carcinoma using computed tomography. Cancer. 2000;89:1532–40.
31. Vergote I, Trope CG, Amant F, et al. Neoadjuvant chemotherapy is the better treatment option in some patients with stage IIIc to IV ovarian cancer. J Clin Oncol. 2011;29:4076–8.
32. Fagotti A, Fanfani F, Ludovisi M, et al. Role of laparoscopy to assess the chance of optimal cytoreductive surgery in advanced ovarian cancer: a pilot study. Gynecol Oncol. 2005;96:729–35.
33. Vergote I, De Wever I, Tjalma W, et al. Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients. Gynecol Oncol. 1998;71:431–6.
34. Vergote I, Trope CG, Amant F, et al. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. N Engl J Med. 2010;363:943–53.
35. Bristow RE, Montz FJ, Lagasse LD, et al. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer. Gynecol Oncol. 1999;72:278.
36. Angioli R, Palaia I, Zullo MA, et al. Diagnostic open laparoscopy in the management of advanced ovarian cancer. Gynecol Oncol. 2006;100:455–61.
37. Rahaman J, Dottino P, Jennings TS, et al. The second-look operation improves survival in suboptimally debulked stage III ovarian cancer patients. Int J Gynecol Cancer. 2005;15:19–25.
38. Anaf V, Gangji D, Simon P, et al. Laparoscopical insertion of intraperitoneal catheters for intraperitoneal chemotherapy. Acta Obstet Gynecol Scand. 2003;82:1140–5.
39. Amara DP, Nezhat C, Teng N, et al. Operative laparoscopy in the management of ovarian cancer. Surg Laparosc Endosc. 1996;6:38–45.
40. Trinh H, Ott C, Fanning J. Feasibility of laparoscopic debulking with electrosurgical loop excision procedure and argon beam coagulator at recurrence in patients with previous laparotomy debulking. Am J Obstet Gynecol. 2004;190:1394–7.
41. Nezhat F, DeNoble S, Brown D, et al. The safety and efficacy of laparoscopic cytoreduction of recurrent ovarian, fallopian tube, and primary peritoneal cancers”. 19th Annual Meeting and Endo Expo of the Society of Laparoendoscopic Surgeons, New York, New York, September 1–4, 2010.
42. Nezhat FR, DeNoble, SM, Liu CS, et al. The safety and efficacy of laparoscopic surgical staging and debulking of apparent advanced stage ovarian, fallopian tube, and primary peritoneal cancers. JSLS. 2010;14:155–68.
43. Fanning J, Yacoub E, Hojat R. Laparoscopic-assisted cytoreduction for primary ovarian cancer: success, morbidity and survival. Gynecol Oncol. 2011;123:47–9.
44. Nezhat F, Yadav J, Rahaman J, et al. Laparoscopic lymphadenectomy for gynecologic malignancies using ultrasonically activated shears: analysis of first 100 cases. Gynecol Oncol. 2005;97:813–19.
45. Brotherton J, McCarus S, Redan J, et al. Hand-assisted laparoscopic surgery for the gynecologic surgeon. JSLS. 2009;13:484–8.
46. Krivak TC, Elkas JC, Rose GS, et al. The utility of hand-assisted laparoscopy in ovarian cancer. Gynecol Oncol. 2005;96:72–6.
47. Spannuth WA, Rocconi RP, Huh WK, et al. A comparison of hand-assisted laparoscopy and conventional laparotomy for the surgical evaluation of pelvic masses. Gynecol Oncol. 2005;99:443–6.
48. Klingler PJ, Smith SL, Abendstein BJ, et al. Hand assisted laparoscopic splenectomy for isolated splenic metastasis from an ovarian carcinoma. Surg Laparosc Endosc. 1997;8:49–54.
49. Pelosi MA, Pelsoi MA III, Eim J. Hand assisted laparoscopy for pelvic malignancy. J Laparoendosc Adv Surg Tech. 2000;10:143–50.
50. Spannuth WA, Rocconi RP, Huh WK, et al. A comparison of hand-assisted laparoscopy and conventional laparotomy for the surgical evaluation of pelvic masses. Gynecol Oncol. 2005;99:443–6.
51. Schlaerth AC, Abu-Rustum NR. Role of minimally invasive surgery in gynecologic cancers. Oncologist. 2006;11:895–901.
52. Chi DS, Abu-Rustum NR, Sonoda Y, et al. Laparoscopic and hand-assisted laparoscopic splenectomy for recurrent and persistent ovarian cancer. Gynecol Oncol. 2006;101:224–7.
53. Cho JE, Shamshirsaz AHA, Nezhat C, et al. New technologies for reproductive medicine: laparoscopy, endoscopy, robotic surgery and gynecology. A review of the literature. Minerva Ginecol. 2010;62:137–67.
54. Magrina JF, Zanagnolo V, Noble BN, et al. Robotic approach for ovarian cancer: perioperative and survival results and comparison with laparoscopy and laparotomy. Gynecol Oncol. 2011;121:100–5.
55. Childers JM, Aqua KA, Surwit EA, et al. Abdominal-wall tumor implantation after laparoscopy for malignant conditions. Obstet Gynecol. 1994;84:765–9.
56. Ramirez PT, Wolf JK, Leveback C. Laparoscopic port-site metastases: etiology and prevention. Gynecol Oncol. 2003;91:179–89.
57. Morice P, Camatte S, Larregain-Fournier D, et al. Port-site implantation after laparoscopic treatment of borderline ovarian tumors. Obstet Gynecol. 2004;104:1167–70.
58. Nagarsheth NP, Rahaman J, Cohen CJ, et al. The incidence of port-site metastases in gynecologic cancers. JSLS. 2004;8:133–9.
59. Vergote I, Marquette S, Arnant F, et al. Port-site metastases after open laparoscopy: a study in 173 patients with advanced ovarian carcinoma. Int J Gynecol Cancer. 2005;15:776–9.
60. Huang KG, Wang CJ, Chang TC, et al. Management of port-site metastases after laparoscopic surgery for ovarian cancer. Am J Obstet Gynecol. 2003;189:16–21.
61. Morice P, Camatte S, Larregain-Fournier D, et al. Port-site implantation after laparoscopic treatment of borderline ovarian tumors. Obstet Gynecol. 2004;104:1167–70.
62. Smidt VJ, Singh DM, Hurteau JA, et al. Effect of carbon dioxide on human ovarian carcinoma cell growth. Am J Obstet Gynecol. 2001:185:1314–17.
63. Dorrance HR, Oien K, O’Dwyer PJ. Effects of laparoscopy on intraperitoneal tumor growth and distant metastases in an animal model. Surgery. 1990;125:35–40.
64. Abu-Rustum NR, Sonoda Y, Chi DS, et al. The effects of CO2 pneumoperitoneum on the survival of women with persistent metastatic ovarian cancer. Gynecol Oncol. 2003;90:431–4.
65. Vaisbuch E, Dgani R, Ben-Arie A, et al. The role of laparoscopy in ovarian tumors of low malignant potential and early-stage ovarian cancer. Obstet Gynecol Surv. 2005;60:326–30.
66. Chi DS, Curtin JP. Gynecologic cancer and laparoscopy. Obstet Gynecol Clin North Am. 1999;26:201–15.
67. Folkins AK, Jarobe EA, Roh MH, et al. Precursors to pelvic serous carcinoma and their clinical implications. Gynecol Oncol. 2009;113:391–6.
68. Pejovic T, Nezhat F. Missing link: inflammation and ovarian cancer. Lancet Oncol. 2011;12:833–4.
69. Roh MH, Kindelberger D, Crum CP. Serous tubal intraepithelial carcinoma and the dominant ovarian mass. Am J Surg Pathol. 2009;33:376–83.
70. Shaw PA, Rouzbahman M, Pizer ES, et al. Candidate serous cancer precursors in fallopian tube epithelium of BRCA 1/2 mutation carriers. Mod Pathol. 2009;22:1133–8.
71. Nezhat F, Datta M, Hanson V, et al. The relationship of endometriosis and ovarian malignancy: a review. Fertil Steril. 2008;90:1559–70.
72. Powell CB, Kenley E, Chen LM, et al. Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy. J Clin Oncol. 2005;23:127–32.
73. Finch A, Shaw P, Rosen B, et al. Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers. Gynecol Oncol. 2006;100:58–64.
74. Callahan MJ, Crum CP, Medeiros F, et al. Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction. J Clin Oncol. 2007;25:3985–90.
75. Leeper K, Garcia R, Swisher E, et al. Pathologic findings in prophylactic oophorectomy specimens in high-risk women. Gynecol Oncol. 2002;87:52–6.
76. Kindelberger DW, Lee Y, Miron A, et al. Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship. Am J Surg Pathol. 2007;31:161–9.
77. Carlson JW, Miron A, Jarboe EA, et al. Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention. J Clin Oncol. 2008;26:4160–5.
78. Querleu D, Papageorgiou T, Lambaudie E, et al. Laparoscopic restaging of borderline ovarian tumors: results of 30 cases initially presumed as stage IA borderline ovarian tumors. BJOG. 2003;110:201–4.
79. Desfeux P, Camatte S, Chatellier G, et al. Impact of surgical approach on the management of macroscopic early ovarian borderline tumors. Gynecol Oncol. 2005;98:390–5.
80. Romagnolo C, Gadducci A, Sartori E, et al. Management of borderline ovarian tumors: results of an Italian multicenter study. Gynecol Oncol. 2006;101:255–60.
81. Brosi N, Deckardt R. Endoscopic surgery in patients with borderline tumor of the ovary: a follow-up study of thirty-five patients. J Minim Invasive Gynecol. 2007;14:606–9.
82. Pomel C, Provencher D, Dauplat J, et al. Laparoscopic staging of early ovarian cancer. Gynecol Oncol. 1995;58:301–6.
83. Chi DS, Abu-Rustum NR, Sonoda Y, et al. The safety and efficacy of laparoscopic surgical staging of apparent stage I ovarian and fallopian tube cancers. Am J Obstet Gynecol. 2005;192:1614–19.
84. Ghezzi F, Cromi A, Uccella S, et al. Laparoscopy versus laparotomy for the surgical management of apparent early stage ovarian cancer. Gynecol Oncol. 2007;105:409–13.
85. Park JY, Bae J, Lim MC, et al. Laparoscopic and laparotomic staging in stage I epithelial ovarian cancer: a comparison of feasibility and safety. Int J Gynecol Cancer. 2008;15:2012–19.
86. Colomer AT, Jimenez AM, Bover Barcelo M. Laparoscopic treatment and staging of early ovarian cancer. J Minim Invasive Gynecol. 2008;15:414–9.